New York Medical College

This study is for people with certain types of B-cell or Hodgkin lymphoma. Participants first get a stem cell transplant using their own cells, then receive a targeted drug called polatuzumab vedotin every 3 weeks for up to 8 doses. The goal is to see if this approach is safe and…

This study is for people who developed a serious liver condition called sinusoidal obstructive syndrome (SOS) after a stem cell transplant and did not get better with standard defibrotide treatment. Researchers want to see if giving higher doses of defibrotide is safe and tolerab…

This study tests whether immune cells (called T cells) taken from a family member who recovered from COVID-19 can safely help treat mild-to-moderate COVID-19 in hospitalized adults. The cells are designed to target the virus. The trial includes 50 participants and aims to see if …